ECOG-ACRIN E1910

Primary Category:

Treatment Protocols

Disease Category:

Acute Lymphocytic Leukemia, Leukemia

Status:

Closed

A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B lineage Acute Lymphoblastic Leukemia in Adults

Eligible for screening study DCP 001

NCT#02003222

Due to the completion of accrual, E1910 will be closed to accrual effective October 15, 2019.

Leave a Reply